4801 related articles for article (PubMed ID: 2961717)
1. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
Kure S; Yoshie O; Aso H
Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
3. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
Kure S; Yoshie O
J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
Keren Z; Leland F; Nakajima M; LeGrue SJ
Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
6. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
8. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
Irimura T; Gonzalez R; Nicolson GL
Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
[TBL] [Abstract][Full Text] [Related]
10. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
11. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
Nabi IR; Raz A
Cancer Res; 1988 Mar; 48(5):1258-64. PubMed ID: 3342405
[TBL] [Abstract][Full Text] [Related]
12. The influence of cell surface properties on the arrest of circulating melanoma cells.
Poste G
Prog Clin Biol Res; 1980; 41():737-45. PubMed ID: 7192863
[TBL] [Abstract][Full Text] [Related]
13. The involvement of thrombin RGD in metastasis: characterization of a cryptic adhesive site.
Bar-Shavit R; Ginzburg Y; Maoz M; Vlodavsky I; Peretz T
Isr J Med Sci; 1995; 31(2-3):86-94. PubMed ID: 7744600
[TBL] [Abstract][Full Text] [Related]
14. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
16. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
Nicolson GL; Dulski K; Basson C; Welch DR
Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
Ricoveri W; Cappelletti R
Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
[TBL] [Abstract][Full Text] [Related]
18. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
Kobayashi M; Kobayashi H; Pollard RB; Suzuki F
J Immunol; 1998 Jun; 160(12):5869-73. PubMed ID: 9637498
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
Gilbert LC; Gordon SG
Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
[TBL] [Abstract][Full Text] [Related]
20. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
